The GOLMePsA study protocol: An investigator-initiated, double-blind, parallelgroup, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Số trang: 13
Loại file: pdf
Dung lượng: 2.45 MB
Lượt xem: 7
Lượt tải: 0
Xem trước 2 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Psoriatic arthritis (PsA) is a chronic inflammatory arthritis which impacts significantly on the quality of life and work capacity of affected individuals. Recent evidence has shown that early control of inflammation in PsA leads to improved long-term outcomes.
Nội dung trích xuất từ tài liệu:
The GOLMePsA study protocol: An investigator-initiated, double-blind, parallelgroup, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Nội dung trích xuất từ tài liệu:
The GOLMePsA study protocol: An investigator-initiated, double-blind, parallelgroup, randomised, controlled trial of GOLimumab and methotrexate versus methotrexate in early diagnosed psoriatic arthritis using clinical and whole body MRI outcomes
Tìm kiếm theo từ khóa liên quan:
BMC Musculoskeletal Disorders Psoriatic arthritis Early diagnosis Treatment-näive TNF-inhibitor Treat-to-target Minimal disease activityTài liệu liên quan:
-
Predicting short stay total hip arthroplasty by use of the timed up and go-test
7 trang 26 0 0 -
12 trang 25 0 0
-
10 trang 24 0 0
-
Risk factors for musculoskeletal pain amongst nurses in Estonia: A cross-sectional study
7 trang 23 0 0 -
Evaluation of C-Reactive protein (CRP) in early diagnosis of Neonatal Septicemia
7 trang 23 0 0 -
6 trang 21 0 0
-
10 trang 21 0 0
-
15 trang 19 0 0
-
11 trang 19 0 0
-
12 trang 18 0 0